IL6 and diabetes mellitus: Pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β), tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), are elevated in patients with diabetes [10,11,12] and have been shown to alter glucose metabolism through various signalling pathways [13].